help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfeffer, U.
Right arrow Articles by Albini, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfeffer, U.
Right arrow Articles by Albini, A.
Endocrinology Vol. 143, No. 8 3114-3121
Copyright © 2002 by The Endocrine Society


ARTICLE

Human Chorionic Gonadotropin Inhibits Kaposi’s Sarcoma Associated Angiogenesis, Matrix Metalloprotease Activity, and Tumor Growth

Ulrich Pfeffer, Davide Bisacchi, Monica Morini, Roberto Benelli, Simona Minghelli, Angelo Vacca, Douglas M. Noonan and Adriana Albini

Laboratory of Molecular Biology (U.P., D.B., R.B., S.M., A.A.) and Tumor Progression Section (M.M., D.M.N.), National Cancer Research Institute Genova, c/o Advanced Biotechnology Center Genova, Genova 16132, Italy; and Department of Biomedical Sciences and Human Oncology (A.V.), University of Bari, Bari 70124, Italy

Address all correspondence and requests for reprints to: Adriana Albini, Laboratory of Molecular Biology, National Cancer Research Institute Genoa, Largo Rosanna Benzi 10, 16132 Genova, Italy. E-mail: . albini{at}cba.unige.it

Kaposi’s sarcoma is a highly angiogenic, AIDS-associated neoplasm that is more frequent in male than in female patients. Cases of spontaneous regression during pregnancy have been reported and the pregnancy hormone human chorionic gonadotropin (hCG) has shown anti-Kaposi’s sarcoma activity in several, but not all, clinical trials. Antiproliferative and proapoptotic activities specific for Kaposi’s sarcoma (KS) cells have been shown. We report here further analyses of the anti-KS activity of the hormone and show that urinary hCG, the hCG ß-subunit, the hCG ß-core, and to a lesser extent a recombinant hCG, directly inhibit the activity of matrix metalloproteases of different origin. The hCG hormone also inhibited angiogenesis in vivo in the matrigel sponge assay as well as growth of KS cell xenografts in nude mice. The effect of the pure recombinant hormone dimer on xenograft growth was transient, indicating that the activity of intact hCG alone is not sufficient to overcome the growth potential of this tumor and suggesting that active hCG fragments or other anti-KS activities contribute to the activity of urinary hCG.




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
A. Lisco, M. Barbierato, J. R. Fiore, P. Gasperini, A. Favia, A. Volpe, M. Chironna, G. Pastore, L. Chieco-Bianchi, and M. L. Calabro
Pregnancy and Human Herpesvirus 8 Reactivation in Human Immunodeficiency Virus Type 1-Infected Women
J. Clin. Microbiol., November 1, 2006; 44(11): 3863 - 3871.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society